| Drug Type Prophylactic vaccine, Multivalent vaccine | 
| Synonyms Combined COVID19 and quadrivalent seasonal influenza vaccine, Coronavirus + Influenza Combo Patch Vaccine, Coronavirus and Influenza Combo Patch Vaccine Medigen Vaccine Biologics/Vaxess Technologies | 
| Target- | 
| Action stimulants | 
| Mechanism Immunostimulants | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization | 
| Drug Highest PhasePendingPreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| COVID-19 | Preclinical | United States  | 14 Sep 2020 | |
| COVID-19 | Preclinical | United States  | 14 Sep 2020 | |
| COVID-19 | Preclinical | Taiwan Province  | 14 Sep 2020 | |
| COVID-19 | Preclinical | Taiwan Province  | 14 Sep 2020 | |
| Influenza, Human | Preclinical | United States  | 14 Sep 2020 | |
| Influenza, Human | Preclinical | United States  | 14 Sep 2020 | |
| Influenza, Human | Preclinical | Taiwan Province  | 14 Sep 2020 | |
| Influenza, Human | Preclinical | Taiwan Province  | 14 Sep 2020 | 





